Exhibit 31.1

CERTIFICATION

Pursuant
to the requirements of Rules 13a-14 of the Securities Exchange Act of 1934, as
amended, James R. Musick provides the following certification.

I,
James R. Musick, President, Chief Executive Officer, Chairman of the Board of Directors
and Principal Financial Officer  of Vitro Diagnostics, Inc. (Company) certify
that:

|1. |  | I have reviewed this quarterly report on Form 10-QSB of the Company;
|-- |  | --------------------------------------------------------------------

|2. |  | Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;
|-- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. |  | Based on my knowledge, the financial statements, and other financial information
included in the quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the Company as of,
and for, the periods presented in this quarterly report;
|-- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|4. |  | I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15-d-14) for the
registrant and have designed such disclosure controls and procedures to ensure
that material information relating to the Company is made know to me by others,
particularly during the period in which this quarterly report is being prepared;
|-- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|5. |  | I have disclosed, based on my most recent evaluation, to the Companys
auditors and the audit committee of our board of directors (or persons
performing the equivalent functions):
|-- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|a. |  | All significant deficiencies in the design or operation of internal controls which could
adversely affect the Companys ability to record, process, summarize and report
financial date and have identified for the Companys auditors any material weaknesses
in internal controls, and
|-- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|b. |  | Any fraud, whether or not material, that involves management or other employees which have
a significant role in the Companys internal controls; and
|-- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------

|6. |  | I have indicated in this quarterly report whether or not there were significant
changes in internal control or in other factors that could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.
|-- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: March 15,
2007

| | By:    /s/
James R. MusickJames R. Musick, President, Chief Executive Officer,Chairman of the Board
of Directors, andPrincipal Financial Officer
| | ------------------------------------------------------------------------------------------------------------------------------------------------